HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

Endocrine-Related Cancer
Supplementary Material

Supplementary material related to the following articles is available online:

From the Current Issue: 17 (2); [Table of Contents]

The current issue doesn't have any supplementary material.

From Past Issues:

Yu-cheng Wang, Marlene B Zuraek, Yasuhiro Kosaka, Yasuharu Ota, Michael S German, Evan S Deneris, Emily K Bergsland, David B Donner, Robert S Warren, and Eric K Nakakura

The ETS oncogene family transcription factor FEV identifies serotonin-producing cells in normal and neoplastic small intestine
ERC 2010; 17(1): 283-291 [Abstract] [Full Text]  

Article supplement(s): [Supplementary Data]

Ton van Agthoven, Anieta M Sieuwerts, Danielle Meijer, Marion E Meijer-van Gelder, Thecla L A van Agthoven, Roya Sarwari, Stefan Sleijfer, John A Foekens, and Lambert C J Dorssers

Selective recruitment of breast cancer anti-estrogen resistance genes and relevance for breast cancer progression and tamoxifen therapy response
ERC 2010; 17(1): 215-230 [Abstract] [Full Text]  

Article supplement(s): [Supplementary Data]

S Corbetta, V Vaira, V Guarnieri, A Scillitani, C Eller-Vainicher, S Ferrero, L Vicentini, I Chiodini, M Bisceglia, P Beck-Peccoz, S Bosari, and A Spada

Differential expression of microRNAs in human parathyroid carcinomas compared with normal parathyroid tissue
ERC 2010; 17(1): 135-146 [Abstract] [Full Text]  

Article supplement(s): [Supplementary Data]

Kristian Unger, Johannes Wienberg, Andrew Riches, Ludwig Hieber, Axel Walch, Andreas Brown, Patricia C M O'Brien, Cäcilia Briscoe, Lindsey Gray, Elke Rodriguez, Gerhard Jackl, Jeroen Knijnenburg, Giovanni Tallini, Malcolm Ferguson-Smith, and Horst Zitzelsberger

Novel gene rearrangements in transformed breast cells identified by high-resolution breakpoint analysis of chromosomal aberrations
ERC 2010; 17(1): 87-98 [Abstract] [Full Text]  

Article supplement(s): [Supplementary Data]

D Alwyn Dart, Bradley Spencer-Dene, Simon C Gamble, Jonathan Waxman, and Charlotte L Bevan

Manipulating prohibitin levels provides evidence for an in vivo role in androgen regulation of prostate tumours
ERC 2009; 16(4): 1157-1169 [Abstract] [Full Text]  

Article supplement(s): [Supplementary Data]

Filippo Montemurro and Massimo Aglietta

Hormone receptor-positive early breast cancer: controversies in the use of adjuvant chemotherapy
ERC 2009; 16(4): 1091-1102 [Abstract] [Full Text]  

Article supplement(s): [Supplementary Data]

Marie-Lise Jaffrain-Rea, Mariolina Angelini, Donatella Gargano, Maria A Tichomirowa, Adrian F Daly, Jean-François Vanbellinghen, Emanuela D'Innocenzo, Anne Barlier, Felice Giangaspero, Vincenzo Esposito, Luca Ventura, Antonietta Arcella, Marily Theodoropoulou, Luciana A Naves, Carmen Fajardo, Sabina Zacharieva, Vincent Rohmer, Thierry Brue, Alberto Gulino, Giampaolo Cantore, Edoardo Alesse, and Albert Beckers

Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications
ERC 2009; 16(3): 1029-1043 [Abstract] [Full Text]  

Article supplement(s): [Supplementary Data]

Ellinor Andersson, Christina Swärd, Göran Stenman, Håkan Ahlman, and Ola Nilsson

High-resolution genomic profiling reveals gain of chromosome 14 as a predictor of poor outcome in ileal carcinoids
ERC 2009; 16(3): 953-966 [Abstract] [Full Text]  

Article supplement(s): [Supplementary Data]

Emelyne Dejeux, Robert Olaso, Bertrand Dousset, Anne Audebourg, Ivo G Gut, Benoit Terris, and Jörg Tost

Hypermethylation of the IGF2 differentially methylated region 2 is a specific event in insulinomas leading to loss-of-imprinting and overexpression
ERC 2009; 16(3): 939-952 [Abstract] [Full Text]  

Article supplement(s): [Supplementary Data]

Cristina L Ronchi, Silviu Sbiera, Luitgard Kraus, Sebastian Wortmann, Sarah Johanssen, Patrick Adam, Holger S Willenberg, Stefanie Hahner, Bruno Allolio, and Martin Fassnacht

Expression of excision repair cross complementing group 1 and prognosis in adrenocortical carcinoma patients treated with platinum-based chemotherapy
ERC 2009; 16(3): 907-918 [Abstract] [Full Text]  

Article supplement(s): [Supplementary Data]

Zsófia Tömböl, Peter M Szabó, Viktor Molnár, Zoltán Wiener, Gergely Tölgyesi, János Horányi, Peter Riesz, Peter Reismann, Attila Patócs, István Likó, Rolf-Christian Gaillard, András Falus, Károly Rácz, and Peter Igaz

Integrative molecular bioinformatics study of human adrenocortical tumors: microRNA, tissue-specific target prediction, and pathway analysis
ERC 2009; 16(3): 895-906 [Abstract] [Full Text]  

Article supplement(s): [Supplementary Data]

Shu Zhang, Ping Lei, Xinyi Liu, Xiangrong Li, Kelcey Walker, Leela Kotha, Craig Rowlands, and Stephen Safe

The aryl hydrocarbon receptor as a target for estrogen receptor-negative breast cancer chemotherapy
ERC 2009; 16(3): 835-844 [Abstract] [Full Text]  

Article supplement(s): [Supplementary Data]

Maya Dadiani, Dalia Seger, Tamar Kreizman, Daria Badikhi, Raanan Margalit, Raya Eilam, and Hadassa Degani

Estrogen regulation of vascular endothelial growth factor in breast cancer in vitro and in vivo: the role of estrogen receptor and c-Myc
ERC 2009; 16(3): 819-834 [Abstract] [Full Text]  

Article supplement(s): [Supplementary Data]

Petra Massoner, Daniela Colleselli, Andrea Matscheski, Haymo Pircher, Stephan Geley, Pidder Jansen Dürr, and Helmut Klocker

Novel mechanism of IGF-binding protein-3 action on prostate cancer cells: inhibition of proliferation, adhesion, and motility
ERC 2009; 16(3): 795-808 [Abstract] [Full Text]  

Article supplement(s): [Supplementary Data]

P S H Soon, A J Gill, D E Benn, A Clarkson, B G Robinson, K L McDonald, and S B Sidhu

Microarray gene expression and immunohistochemistry analyses of adrenocortical tumors identify IGF2 and Ki-67 as useful in differentiating carcinomas from adenomas
ERC 2009; 16(2): 573-583 [Abstract] [Full Text]  

Article supplement(s): [Supplementary Data]

Stéphanie Durand, Carole Ferraro-Peyret, Mireille Joufre, Annie Chave, Françoise Borson-Chazot, Samia Selmi-Ruby, and Bernard Rousset

Molecular characteristics of papillary thyroid carcinomas without BRAF mutation or RET/PTC rearrangement: relationship with clinico-pathological features
ERC 2009; 16(2): 467-481 [Abstract] [Full Text]  

Article supplement(s): [Supplementary Data]

Ashish Shukla, Jean Grisouard, Volker Ehemann, Alexander Hermani, Harald Enzmann, and Doris Mayer

Analysis of signaling pathways related to cell proliferation stimulated by insulin analogs in human mammary epithelial cell lines
ERC 2009; 16(2): 429-441 [Abstract] [Full Text]  

Article supplement(s): [Supplementary Data]

D Engelmann, D Koczan, P Ricken, U Rimpler, J Pahnke, Z Li, and B M Pützer

Transcriptome analysis in mouse tumors induced by Ret-MEN2/FMTC mutations reveals subtype-specific role in survival and interference with immune surveillance
ERC 2009; 16(1): 211-224 [Abstract] [Full Text]  

Article supplement(s): [Supplementary Data]

Caroline D E Margetts, Mark Morris, Dewi Astuti, Dean C Gentle, Alberto Cascon, Fiona E McRonald, Daniel Catchpoole, Mercedes Robledo, Hartmut P H Neumann, Farida Latif, and Eamonn R Maher

Evaluation of a functional epigenetic approach to identify promoter region methylation in phaeochromocytoma and neuroblastoma
ERC 2008; 15(3): 777-786 [Abstract] [Full Text]  

Article supplement(s): [Supplementary Data]

Heng Hong Lee, Yansong Zhu, Karthik M Govindasamy, and Ganesan Gopalan

Downregulation of Aurora-A overrides estrogen-mediated growth and chemoresistance in breast cancer cells
ERC 2008; 15(3): 765-775 [Abstract] [Full Text]  

Article supplement(s): [Supplementary Data]

N B Kiss, J Geli, F Lundberg, C Avci, D Velazquez-Fernandez, J Hashemi, G Weber, A Höög, T J Ekström, M Bäckdahl, and C Larsson

Methylation of the p16^INK4A promoter is associated with malignant behavior in abdominal extra-adrenal paragangliomas but not pheochromocytomas
ERC 2008; 15(2): 609-621 [Abstract] [Full Text]  

Article supplement(s): [Supplementary Data]

Vera Cappelletti, Manuela Gariboldi, Loris De Cecco, Sara Toffanin, James F Reid, Lara Lusa, Emilio Bajetta, Luigi Celio, Marco Greco, Alessandra Fabbri, Marco A Pierotti, and Maria Grazia Daidone

Patterns and changes in gene expression following neo-adjuvant anti-estrogen treatment in estrogen receptor-positive breast cancer
ERC 2008; 15(2): 439-449 [Abstract] [Full Text]  

Article supplement(s): [Supplementary Data]

H-C Jennifer Shen, Jennifer E Rosen, Lauren M Yang, Sharon A Savage, A Lee Burns, Carmen M Mateo, Sunita K Agarwal, Settara C Chandrasekharappa, Allen M Spiegel, Francis S Collins, Stephen J Marx, and Steven K Libutti

Parathyroid tumor development involves deregulation of homeobox genes
ERC 2008; 15(1): 267-275 [Abstract] [Full Text]  

Article supplement(s): [Supplementary Data]

Eva-Maria Duerr, Yusuke Mizukami, Aylwin Ng, Ramnik J Xavier, Hirotoshi Kikuchi, Vikram Deshpande, Andrew L Warshaw, Jonathan Glickman, Matthew H Kulke, and Daniel C Chung

Defining molecular classifications and targets in gastroenteropancreatic neuroendocrine tumors through DNA microarray analysis
ERC 2008; 15(1): 243-256 [Abstract] [Full Text]  

Article supplement(s): [Supplemental Data]

S Fontanière, J Tost, A Wierinckx, J Lachuer, J Lu, N Hussein, F Busato, I Gut, Z-Q Wang, and C-X Zhang

Gene expression profiling in insulinomas of Men1 ß-cell mutant mice reveals early genetic and epigenetic events involved in pancreatic ß-cell tumorigenesis
ERC 2006; 13(4): 1223-1236 [Abstract] [Full Text]  

Article supplement(s): [Supplementary Data]

S Tozlu, I Girault, S Vacher, J Vendrell, C Andrieu, F Spyratos, P Cohen, R Lidereau, and I Bieche

Identification of novel genes that co-cluster with estrogen receptor alpha in breast tumor biopsy specimens, using a large-scale real-time reverse transcription-PCR approach
ERC 2006; 13(4): 1109-1120 [Abstract] [Full Text]  

Article supplement(s): [Supplementary Data]

S Rinaldi, P H M Peeters, F Berrino, L Dossus, C Biessy, A Olsen, A Tjonneland, K Overvad, F Clavel-Chapelon, M C Boutron-Ruault, B Téhard, G Nagel, J Linseisen, H Boeing, P H Lahmann, A Trichopoulou, D Trichopoulos, M Koliva, D Palli, S Panico, R Tumino, C Sacerdote, C H van Gils, P van Noord, D E Grobbee, H B Bueno-de-Mesquita, C A Gonzalez, A Agudo, M D Chirlaque, A Barricarte, N Larrañaga, J R Quiros, S Bingham, K T Khaw, T Key, N E Allen, A Lukanova, N Slimani, R Saracci, E Riboli, and R Kaaks

IGF-I, IGFBP-3 and breast cancer risk in women: The European Prospective Investigation into Cancer and Nutrition (EPIC)
ERC 2006; 13(2): 593-605 [Abstract] [Full Text]  

Article supplement(s): [Link to related commentary]

Eva S Schernhammer, Jeff M Holly, David J Hunter, Michael N Pollak, and Susan E Hankinson

Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II
ERC 2006; 13(2): 583-592 [Abstract] [Full Text]  

Article supplement(s): [Link to related commentary]

G Capurso, S Lattimore, T Crnogorac-Jurcevic, F Panzuto, M Milione, V Bhakta, N Campanini, S M Swift, C Bordi, G Delle Fave, and N R Lemoine

Gene expression profiles of progressive pancreatic endocrine tumours and their liver metastases reveal potential novel markers and therapeutic targets
ERC 2006; 13(2): 541-558 [Abstract] [Full Text]  

Article supplement(s): [Supplementary Table]

Andrew G Renehan, Michelle Harvie, and Anthony Howell

Insulin-like growth factor (IGF)-I, IGF binding protein-3, and breast cancer risk: eight years on
ERC 2006; 13(2): 273-278 [Abstract] [Full Text]  

Article supplement(s): [Link to related articles]

Adriano Angelucci, Giovanni Luca Gravina, Nadia Rucci, Danilo Millimaggi, Claudio Festuccia, Paola Muzi, Anna Teti, Carlo Vicentini, and Mauro Bologna

Suppression of EGF-R signaling reduces the incidence of prostate cancer metastasis in nude mice
ERC 2006; 13(1): 197-210 [Abstract] [Full Text]  

Article supplement(s): [Link to Commentary]

Nicola Normanno and William J Gullick

Epidermal growth factor receptor tyrosine kinase inhibitors and bone metastases: different mechanisms of action for a novel therapeutic application?
ERC 2006; 13(1): 3-6 [Abstract] [Full Text]  

Article supplement(s): [Link to related article]